日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

晚期前列腺癌患者的管理:2015年圣加仑晚期前列腺癌共识会议(APCCC)的建议

Gillessen, S; Omlin, A; Attard, G; de Bono, J S; Efstathiou, E; Fizazi, K; Halabi, S; Nelson, P S; Sartor, O; Smith, M R; Soule, H R; Akaza, H; Beer, T M; Beltran, H; Chinnaiyan, A M; Daugaard, G; Davis, I D; De Santis, M; Drake, C G; Eeles, R A; Fanti, S; Gleave, M E; Heidenreich, A; Hussain, M; James, N D; Lecouvet, F E; Logothetis, C J; Mastris, K; Nilsson, S; Oh, W K; Olmos, D; Padhani, A R; Parker, C; Rubin, M A; Schalken, J A; Scher, H I; Sella, A; Shore, N D; Small, E J; Sternberg, C N; Suzuki, H; Sweeney, C J; Tannock, I F; Tombal, B

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation

磁共振波谱和增强磁共振成像技术在辅助前列腺异常定位以进行活检方面的诊断准确性和成本效益:系统评价和经济评估

Mowatt, G; Scotland, G; Boachie, C; Cruickshank, M; Ford, J A; Fraser, C; Kurban, L; Lam, T B; Padhani, A R; Royle, J; Scheenen, T W; Tassie, E

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans

吸入高碳氧混合气可增加前列腺癌的氧合作用:一项在小鼠异种移植模型和人类中进行的转化磁共振成像研究

Alonzi, R; Padhani, A R; Maxwell, R J; Taylor, N J; Stirling, J J; Wilson, J I; d'Arcy, J A; Collins, D J; Saunders, M I; Hoskin, P J

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

人类肿瘤血管生成特征与康布瑞他汀诱导的血管关闭之间的关系:一项探索性研究

Gaya A, Daley F, Taylor N J, Tozer G, Qureshi U, Padhani A, Pedley R B, Begent R, Wellsted D, Stirling J J, Rustin G

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI

动态磁共振成像测量铂类/紫杉烷类化疗对人盆腔肿瘤急性灌注的影响

Lankester, K J; Taylor, N J; Stirling, J J; Boxall, J; D'Arcy, J A; Leach, M O; Rustin, G J S; Padhani, A R

A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points.

一项针对实体瘤的血管生成抑制剂 SU5416(semaxanib)的 I 期研究,纳入了动态对比 MR 药效学终点

O'Donnell A, Padhani A, Hayes C, Kakkar A J, Leach M, Trigo J M, Scurr M, Raynaud F, Phillips S, Aherne W, Hardcastle A, Workman P, Hannah A, Judson I

Recent advances in oncological imaging

肿瘤影像学的最新进展

El-Haddad, K S; Padhani, A R

Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

恶性间皮瘤患者化疗联合牛分枝杆菌(SRL172)的临床和免疫学评估

Mendes, R; O'Brien, M E R; Mitra, A; Norton, A; Gregory, R K; Padhani, A R; Bromelow, K V; Winkley, A R; Ashley, S; Smith, I E; Souberbielle, B E

The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours

接受睾丸肿瘤化疗的患者中无血管性坏死的发生率

Cook, A M; Dzik-Jurasz, A S; Padhani, A R; Norman, A; Huddart, R A

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study

FDG-PET在预测胰腺癌患者生存期中的应用:一项初步研究

Maisey, N R; Webb, A; Flux, G D; Padhani, A; Cunningham, D C; Ott, R J; Norman, A